The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Mereo BioPharma Group plc’s current trading price is -9.60% away from its 52-week high, while its distance from the 52-week low is 223.56%. The stock’s price range for this period has been between $0.49 and $1.77 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.69 million for the day, a number notably lower than the average daily volume of 1.06 million over the last three months.
At present, Mereo BioPharma Group plc (MREO) has a stock price of $1.60. In the previous session, the stock saw a rise, peaking at $1.61 after an opening price of $1.46. The day’s lowest price was $1.45, and it closed at $1.44.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Mereo BioPharma Group plc experienced a rather steady stock market performance. The highest value in the past year was recorded at $1.77 on 08/29/23 and the lowest value was $0.49 on 12/23/22.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Mereo BioPharma Group plc (MREO) has experienced a quarterly rise of 15.94% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 224.39M and boasts a workforce of 36 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.2685, with a change in price of +0.6101. Similarly, Mereo BioPharma Group plc recorded 1,592,972 in trading volume during the last 100 days, posting a change of +61.63%.
MREO Stock Stochastic Average
As of today, Mereo BioPharma Group plc’s raw stochastic average for the last 50 days stands at 74.81%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 69.09%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 47.27% and 38.59%, respectively.
MREO Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a gain of 113.33%.However, over the last six months, we can see a weaker performance of 88.24%. Over the last 30 days, the price of MREO has fallen by 26.98%. And in the last five days, it has surged by 11.89%.
